1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Bangladesh Pharmaceuticals and Healthcare Report Q2 2016

Bangladesh Pharmaceuticals and Healthcare Report Q2 2016

  • March 2016
  • -
  • Business Monitor International
  • -
  • 90 pages

Includes 3 FREE quarterly updates

BMI View: While Bangladesh's ambitious goals for pharmaceutical exports are unlikely to be realised, thesector will see modest growth ahead. Emerging markets such as Myanmar will be stable sources of demandeven as opportunities to export to the lucrative developed markets such as the US and the EU grow due tocost containment. A key risk to this stems from the commoditisation of the generic drug sector, which willplace pressure on profit margins, and the competition from the more established Indian pharmaceuticalsector.

Headline Expenditure Projections

- Pharmaceuticals: BDT171.6bn (USD2.2bn) in 2015 to BDT190.8bn (USD2.4bn) in 2016; +11.2% inlocal currency terms and +9.1% in US dollar terms.

- Healthcare: BDT494.0bn (USD6.3bn) in 2015 to BDT554.9bn (USD7.0bn) in 2016; +12.3% in localcurrency terms and +10.3% in US dollar terms.

Table Of Contents

Bangladesh Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Bangladesh 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Bangladesh 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Bangladesh 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Bangladesh 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Bangladesh 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Bangladesh 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Bangladesh 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bangladesh 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Bangladesh 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Bangladesh 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Bangladesh 2014-2020) 28
Pharmaceuticals and Healthcare Risk/Reward Index 29
Asia Pacific Risk/Reward Index 29
Bangladesh Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 37
Table: Steps To Establish A Pharmaceutical Manufacturing Unit And Obtain A Drug Manufacturing Licence 39
Intellectual Property Issues 39
Pricing And Reimbursement Regime 41
Market Overview 44
Healthcare Sector 44
Healthcare Infrastructure 51
Table: Healthcare Resources (Bangladesh 2010-2015) 51
Table: Healthcare Personnel (Bangladesh 2010-2015) 51
Table: Healthcare Activity (Bangladesh 2010-2015) 52
Research And Development 53
Table: Suggestions Made By University Of Dhaka's Faculty Of Pharmacy To Improve Pharmaceutical Research 54
Clinical Trials 55
Epidemiology 56
Competitive Landscape 59
Research-Based Industry 59
Table: Table: Multinational Market Activity 62
Pharmaceutical Distribution 63
Company Profile 64
Beximco Pharmaceuticals 64
Eskayef 67
Renata 70
Sanofi 73
Square Pharmaceuticals 76
Demographic Forecast 79
Table: Population Headline Indicators (Bangladesh 1990-2025) 80
Table: Key Population Ratios (Bangladesh 1990-2025) 80
Table: Urban/Rural Population and Life Expectancy (Bangladesh 1990-2025) 81
Table: Population By Age Group (Bangladesh 1990-2025) 81
Table: Population By Age Group % (Bangladesh 1990-2025) 82
Glossary 84
Methodology 86
Pharmaceutical Expenditure Forecast Model 86
Healthcare Expenditure Forecast Model 86
Notes On Methodology 87
Risk/Reward Index Methodology 88
Index Overview 89
Table: Pharmaceutical Risk/Reward Index Indicators 89
Indicator Weightings 90

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.